Pharmaceutical

Image

Global Glycopeptide Antibiotics Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Glycopeptide Antibiotics Market, By Drugs (Vancomycin, Dalbavancin, Oritavancin, Others), Indication (Skin and Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.

Glycopeptide Antibiotics Market

Glycopeptide Antibiotics Market Analysis and Size

Growing incidence of cancer and other infectious diseases are anticipated to increase the growth during the forecast period. The common glycopeptides that are currently used in clinical practice to treat enterococcal infections are teicoplanin and vancomycin. The growth of glycopeptide antibiotics market is increased by the growing cases of numerous infectious diseases and emerging launches in research and development activities that are conducted by many pharmaceuticals’ companies.

Data Bridge Market Research analyses a growth rate in the glycopeptide antibiotics market in the forecast period 2023-2030. The expected CAGR of glycopeptide antibiotics market is tend to be around 10% in the mentioned forecast period. The market was valued at USD 3.07 billion in 2022, and it would grow up to USD 6.6 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Glycopeptide Antibiotics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drugs (Vancomycin, Dalbavancin, Oritavancin, Others), Indication (Skin and Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

ANI Pharmaceuticals, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Pfizer Inc (U.S.), Mylan N.V. (U.S.), Novartis AG (U.S.), Hikma Pharmaceuticals plc (U.K.), Aurobindo Pharma (India), Allergan (U.S.), Melinta Therapeutics, Inc (U.S.), Cumberland Pharmaceuticals Inc (U.S.), Theravance Biopharma (U.S.), Janssen Global Services, LLC (U.S.), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline plc. (U.K.), Bayer AG (U.S.)

Market Opportunities

  • Increasing Demand of Retail Pharmacies
  • Higher Efficiency of Novel Drugs

Market Definition

Glycopeptide antibiotics are the kind of antibiotic which obstructs bacterial cell wall formation by restricting peptidoglycan synthesis. They are widely used for the treatment of multi-resistant Staphylococcus aureus (MRSA) infections and other enterococcal infections, which are unaffected to beta-lactams and other antibiotics. They are also used in cases where there is an allergy to beta-lactams.

Global Glycopeptide Antibiotics Market Dynamics

Drivers

  • Rising Cases of Cancer and Infectious Diseases

Growing cancer and other infectious diseases are anticipated to boost the market growth during the forecast period 2023-2030. For instance, according to the CDC reports U.S, 1,752,735 new cancer cases combined with 599,589 deaths were observed in 2019. Additionally, according to the records of Globocan 2020, U.K., around 457,960 new cases with 179,648 deaths were reported in 2020. As per the reports, the most common types of malignancies observed were breast, prostate cancer and Non-Hodgkin’s lymphoma. Thus, this growing incidence is demanding higher rate of antibiotics and thus boosting the market growth.

  • Increased Collaborations and Acquisitions

Several collaborations associated with the glycopeptide antibiotics are increasing the market growth. For instance, AbbVie Inc got U.S. FDA approval for DALVANCE in July 2021 for the treatment of acute bacterial skin and other skin structure infections in pediatric patients since birth. Additionally, Sandoz International GmbH launched Daptomycin injection 500 mg, in the U.S. market in July 2020, for treating complicated skin and skin structure infections and numerous type of bloodstream infections. Thus, it boost the market growth.

Opportunities

  • Increasing Demand of Retail Pharmacies

The increase in the number of narcotic drugs which is delivered through retail pharmacies and the rise in the number of retail pharmacies in developing and developed countries create opportunities for the market growth. Additionally, patients choose retail pharmacies for purchasing drugs, as these are easily available.

  • Higher Efficiency of Novel Drugs

The efficiency of several existing products is anticipated to result into increasing revenues due to doctor recommendations. For instance, BLEOMYCIN for injection USP is the mixture of cytotoxic glycopeptide antibiotics which is isolated from Streptomyces verticillus and is widely used for the treatment of testicular carcinoma, squamous cell carcinoma, and various types of lymphomas.

Restraints/Challenges

  • High Cost of Treatment

The increased cost which is required for the numerous treatment methods hinders market growth. Numerous market players make some huge investments in manufacturing advanced treatment procedures to increase the recovery process, and in return, the cost is increased.

This glycopeptide antibiotics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycopeptide antibiotics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Glycopeptide Antibiotics Market Scope

The glycopeptide antibiotics market is segmented on the basis of drugs, indication, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs

  • Vancomycin
  • Dalbavancin
  • Oritavancin
  • Others

Indication

  • Skin and Structure Infection
  • Meningitis
  • Clostridioides Difficile Infection
  •  Enterocolitis
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Glycopeptide Antibiotics Regional Analysis/Insights

The glycopeptide antibiotics market is analyzed and market size insights and trends are provided by drugs, indication, route of administration, end-users and distribution channel as referenced above.

The major countries covered in the glycopeptide antibiotics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market because of the increasing occurrence of asthma, and severe pain and increased drug abuse.

Asia-Pacific is considered to grow over the coming years because of the attracting attention of major market players to establish many emerging economics with significant growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Global Glycopeptide Antibiotics Share Analysis

The glycopeptide antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycopeptide antibiotics market

Key players operating in the glycopeptide antibiotics market include:

  • ANI Pharmaceuticals, Inc. (U.S.)
  • Fresenius SE & Co. KGaA (Germany)
  • Pfizer Inc (U.S.)
  •  Mylan N.V. (U.S.)
  • Novartis AG (U.S.),
  • Hikma Pharmaceuticals plc (U.K.)
  • Aurobindo Pharma (India)
  • Abbvie, Inc (U.S.)
  • Melinta Therapeutics, Inc (U.S.)
  • Cumberland Pharmaceuticals Inc (U.S.)
  • Theravance Biopharma (U.S.)
  • Janssen Global Services, LLC (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • GSK plc. (U.K.)
  • Bayer AG (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Glycopeptide Antibiotics Market is projected to grow at a CAGR of 10.0% during the forecast period by 2030.
The future market value of the Glycopeptide Antibiotics Market is expected to reach USD 6.6 billion by 2030.
The major players in the Glycopeptide Antibiotics Market are ANI Pharmaceuticals, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Pfizer Inc (U.S.), Mylan N.V. (U.S.), Novartis AG (U.S.), Hikma Pharmaceuticals plc (U.K.), Aurobindo Pharma (India), Allergan (U.S.), etc.
The countries covered in the Glycopeptide Antibiotics Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials